Vela Laboratories Announces Renewal of Gmp Certificate For Analytical And Quality Control Laboratories
Published: Sep 08, 2010
“We are pleased that Vela Laboratories has its GMP certification renewed, as this achievement will further strengthen our position as a provider to the global pharmaceutical and biotechnology industry,” said Dr. Markus Fido, co-founder and CEO of Vela Laboratories. “Vela has established a broad analytical method portfolio, serving the needs of manufacturers of Biopharmaceuticals and Biosimilars in Europe, North America, and India, including the characterization of complex proteins like monoclonal antibodies or growth factors.”
“The fact that no findings were made during the inspection demonstrates that our whole team is dedicated to the highest quality standards,” said Dr. Andreas Nechansky, co-founder and COO of Vela Laboratories. “The renewal of the GMP certification for our analytical and Quality Control laboratories confirms that we are on the right track towards our goal of becoming a major player in the analytical services business.”
‘Good Manufacturing Practice’ is a body of internationally accepted regulations set forth by EU and US drug agencies. GMP compliance ensures that pharmaceuticals, active ingredients and medical devices are produced and quality-controlled according to state-of-the-art standards. GMP compliance is the gold standard in quality for the life sciences industry.
About Vela Laboratories
Vela Laboratories (Vela pharmazeutische Entwicklung und Laboranalytik GmbH) provides a broad portfolio of analytical methods for the preclinical and clinical development including studies in support of regulatory submissions and product release for Biopharmaceuticals and Biosimilars, including monoclonal antibodies and growth factors.
The Company is headquartered in Vienna, Austria.
For more information on Vela Laboratories, visit www.vela-labs.at
Dr. Markus Fido, CEO Vela Laboratories Brunner Strasse 69 / 3 1230 Vienna Austria +43-1-890 5979 11 email@example.com
Frank Butschbacher Investor Relations & Communications +43-650-7844940 www.butschbacher.net